AmericaFirst Defensive Growth & Income Portfolio Series 2’s Eastman Chemical EMN Stock Holding History

AmericaFirst Defensive Growth & Income Portfolio Series 2’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$174K	Buy	+2,076	New	+$167K	0.22%	103

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AmericaFirst Defensive Growth & Income Portfolio Series 2's EMN Position: Q2 2017 in Review

AmericaFirst Defensive Growth & Income Portfolio Series 2 opened a new position in Eastman Chemical (EMN) in Q2 2017: 2,076 shares worth $174K. The stake represents 0.22% of the portfolio and ranks #103 among its holdings.

618 funds tracked by Wall St. Rank hold EMN as of Q2 2017.

AmericaFirst Defensive Growth & Income Portfolio Series 2 held 2,076 shares of Eastman Chemical worth $174K as of Q2 2017.
Eastman Chemical was a new AmericaFirst Defensive Growth & Income Portfolio Series 2 position in Q2 2017.
Eastman Chemical made up 0.22% of AmericaFirst Defensive Growth & Income Portfolio Series 2's portfolio in Q2 2017, its #103 holding.
618 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2017.

Based on AmericaFirst Defensive Growth & Income Portfolio Series 2's 13F filing for Q2 2017, filed 15 Aug 2017.